188 jili cc jili casino 777
Musk says US is demanding he pay penalty over disclosures of his Twitter stock purchases DETROIT (AP) — Elon Musk says the Securities and Exchange Commission wants him to pay a penalty or face charges involving what he disclosed — or failed to disclose — about his purchases of Twitter stock before he bought the social media platform in 2022. In a letter, Musk’s lawyer Alex Spiro tells the outgoing SEC chairman, Gary Gensler, that the commission’s demand for a monetary payment is a “misguided scheme” that won’t intimidate Musk. The letter also alleges that the commission reopened an investigation this week into Neuralink, Musk’s computer-to-human brain interface company. The SEC has not released the letter. Nor would it comment on it or confirm whether it has issued such a demand to Musk. Senate begins final push to expand Social Security benefits for millions of people WASHINGTON (AP) — The Senate is pushing toward a vote on legislation that would provide full Social Security benefits to millions of people. Senate Majority Leader Chuck Schumer began the process on Thursday for a final vote on the bill, known as the Social Security Fairness Act. It would eliminate policies that currently limit Social Security payouts for roughly 2.8 million people. The legislation has passed the House. The bill would add more strain on the Social Security Trust funds, which are already estimated to be unable to pay out full benefits beginning in 2035. The measure would add an estimated $195 billion to federal deficits over 10 years, according to the Congressional Budget Office. Trump offers support for dockworkers union by saying ports shouldn't install more automated systems WASHINGTON (AP) — President-elect Donald Trump is offering his support for the dockworkers union before their contract expires next month at Eastern and Gulf Coast ports. He posted on social media Thursday that he met with union leaders and that any further “automation” of the ports would harm workers. He wrote that the “amount of money saved is nowhere near the distress, hurt, and harm it causes for American Workers.” The International Longshoremen’s Association has until Jan. 15 to negotiate a new contract with the U.S. Maritime Alliance, which represents ports and shipping companies. The Maritime Alliance says the technology will improve worker safety and strengthen our supply chains, among other things. IRS recovers $4.7 billion in back taxes and braces for cuts with Trump and GOP in power WASHINGTON (AP) — IRS leadership on Thursday announced that the agency has recovered $4.7 billion in back taxes and proceeds from a variety of crimes. The announcement comes under the backdrop of a promised reckoning from Republicans who will hold a majority over both chambers of the next Congress and have long called for rescinding the tens of billions of dollars in funding provided to the agency by Democrats. IRS Commissioner Danny Werfel said improvements made to the agency will help the incoming administration and new Republican majority congress achieve its goals of administering an extension of the 2017 Tax Cuts and Jobs Act. OpenAI's Altman will donate $1 million to Trump's inaugural fund LOS ANGELES (AP) — OpenAI CEO Sam Altman is planning to make a $1 million personal donation to President-Elect Donald Trump’s inauguration fund, joining a number of tech companies and executives who are working to improve their relationships the incoming administration. A spokesperson for OpenAI confirmed the move on Friday. The announcement comes one day after Meta, the parent company of Facebook and Instagram, said it donated $1 million to the same fund. Amazon also said it plans to donate $1 million. China signals it's prepared to double down on support for the economy as Trump tariffs loom BANGKOK (AP) — Chinese leaders met this week to plot economic policy for the coming year and sketched out plans to raise government spending and relax Beijing's monetary policy. Analysts said the broad-brush plans from the annual Central Economic Work Conference were more of a recap of current policy than ambitious new initiatives at a time when the outlook is clouded by the President-elect Donald Trump's threats to sharply raise tariffs once he takes office. The ruling Communist Party did commit to raising China's deficit and to doing more to encourage consumer spending by bringing wage increases in line with the pace of economic growth. Here's a look at China's main priorities and their potential implications. Stock market today: Wall Street slips at the end of a bumpy week Stocks slipped as Wall Street closes out a rare bumpy week. The S&P 500 was down less than 0.1% in afternoon trading Friday and headed for a weekly loss. The benchmark index hit its latest in a string of records a week ago. The Dow Jones Industrial Average fell 25 points. The Nasdaq composite was down less than 0.1%. Broadcom surged after the semiconductor company beat Wall Street’s profit targets and gave a glowing forecast, highlighting its artificial intelligence products. Treasury yields edged higher in the bond market. European markets were mostly lower and Asian markets mostly fell. Next Week: Retail sales, Fed policy update, existing home sales The Commerce Department releases its monthly snapshot of U.S. retail sales Tuesday. Federal Reserve officials wrap up a two-day meeting and issue an interest rate policy update Wednesday. The National Association of Realtors issues its latest update on U.S. home sales Thursday. African Union chairperson candidates advocate for permanent UN Security Council seats NAIROBI, Kenya (AP) — Three African leaders seeking to head the African Union have detailed their plans for regional security amid conflicts and political coups while strongly advocating for inter-Africa trade. The race for chairperson debate was held Friday in Ethiopian capital Addis Ababa. Kenya’s Raila Odinga, Djibouti’s Mahamoud Ali Youssouf and Madagascar’s Richard Randriamandrato are seeking to be elected as chairperson for the 55-member state African Union. They had a two-hour debate Friday in which they all advocated for two permanent seats for African countries at the U.N. Security Council to effectively represent the continent with the youngest population. The three are seeking to convince most African countries before the February election to succeed the African Union Chairperson Moussa Faki. From a 10-year-old to a Muppet to a president-elect, NYSE bell-ringers range from famous to obscure The first guest invited to ring the bell at the New York Stock Exchange in 1956 wasn’t a company executive, a politician or a celebrity. It was a 10-year-old boy, Leonard Ross, who received the honor by winning a television quiz show. Since then, business titans, political giants and global film stars have all been among those ringing the opening bell at the NYSE. Ronald Reagan rang the bell as president in 1985. Billionaire businessman and former New York City Mayor Michael Bloomberg and Hollywood star Robert Downey Jr. have also rung the bell. The even list includes famous Muppets: Miss Piggy was once a bell ringer.
NVIDIA Co. (NASDAQ:NVDA) Shares Bought by Generate Investment Management Ltd
Women more likely to need walking aids but less likely to use them – studyAs Christmas draws closer and temperatures begin to plummet, the temptation to wrap up warm and eat sugary food becomes increasingly appealing. But why does our sugar intake tend to skyrocket this time of year? And is there anything we can do to manage these cravings? Why do we get sugar cravings during the winter? Behaviour conditioning “One of the main reasons is the environmental triggers we’re exposed to during winter,” explains Rosie Carr, dietitian at healthy eating plan Second Nature. “Over many years, we may have built associations in our brains between certain situations and food or drink, like coming home from a cold walk and having a hot chocolate with marshmallows. “Repeating this behaviour will mean our brains crave sugar after walking in cold weather – and this is known as ‘Pavlovian conditioning’ and can be applied to many other environmental, social, and behavioural cues that lead to cravings.” Credits: PA; Biological influence Dopamine, also known as the feel-good hormone, plays a central role in maintaining this craving cycle and reinforcing these behaviours. “The process is regulated by the neurotransmitter dopamine, which is involved in motivation and reward,” explains Carr. “When dopamine is triggered (like when we have a hot chocolate, for example), dopamine is released to instruct the brain to repeat this behaviour.” Some researchers have also suggested a possible link between cold exposure and the hunger hormone ghrelin. “A study conducted on healthy men showed that our ghrelin levels rise when we’re exposed to colder temperatures,” notes Carr. Evolutionary influence “For our ancestors, winter meant many months of harsh conditions that made survival more challenging,” explains Carr. “There may have also been less food to hunt and gather. “So, the colder temperatures may signal to our hunter-gatherer brains to consume more energy-dense foods, lay down fat, and increase our survival chances.” What impact does sugary foods have on our body? “Foods that contain added sugar typically fall under the category of ultra-processed foods, such as cereals, pastries, biscuits, crisps, and other convenience foods like microwave meals,” highlights Carr. “These foods bypass our hunger-regulation network, and research has shown they lead to weight gain.” They’re also more likely to increase our blood sugar levels sharply. “When our blood sugar levels rise above our body’s ideal range, it triggers the release of large insulin levels to bring these levels back to normal,” explains the dietitian. “Unfortunately, this excess release of insulin can then lead to blood sugar crashes, which triggers the release of the stress hormones cortisol and adrenaline to try and avoid hypoglycemia. “This blood sugar rollercoaster can significantly impact our energy levels, brain function, and ability to perform professionally and socially.” What can we do to manage these cravings? Drink plenty of water “If you’re experiencing intense cravings, it’s extremely important that you try to drink plenty of fluids,” says Emma Thornton, nutritionist at A.Vogel. “Not only does this ensure that you can metabolise glycogen, increasing your energy levels, it also means that you can maintain a good balance of electrolytes. “You should be aiming to drink 8-10 glasses of water a day – and this means plain water, not carbonated water or caffeinated drinks.” Credits: PA; Limit consumption of sugary foods “I recommend planning your meals ahead of time and sticking to your shopping list,” advises Carr. “This will ensure you’re limiting the consumption of ultra-processed foods and cooking your meals from fresh ingredients. “If we eat whole foods most of the time, we can enjoy the odd dessert mindfully and without guilt.” Reduce your stress levels “Stress can be disastrous when it comes to encouraging sugar cravings so this is naturally an issue you will want to address,” highlights Thornton. “When it comes to difficult emotions like stress and anxiety, we usually recommend tackling them at the root cause – but this might not always be possible, in which case you may need to think about how to manage your symptoms. “Keeping active, eating the right foods and practicing mindful exercises such as meditation can be great tools to help you here.” Try the urge surfing technique “Ride the wave of the craving for 15 minutes and do something else during this time, like going for a walk or making herbal tea,” recommends Carr. “If you’re still craving something sweet, try swapping in a healthier option like apple and peanut butter, or Greek yoghurt with berries.”
Gold Reserve Reports on Results of Annual General Meeting of Shareholders and Announces Appointment of Additional Directors
San Francisco coach Kyle Shanahan said linebacker De’Vondre Campbell won’t be part of the 49ers moving forward after he refused to enter a game after losing his starting job. Shanahan said the team is still working through the options of how to deal with Campbell, who walked to the locker room in the middle of a 12-6 loss to the Los Angeles Rams on Thursday night when he refused to enter the game. “His actions from the game are not something you can do to your team or teammates and still expect to be a part of our team,” Shanahan said Friday. “We’re working through the semantics right now, but we’ll handle the situation appropriately.” Shanahan said Campbell won’t be part of the team for the final three weeks. Teams have the ability to suspend players up to four games without pay for conduct detrimental to the team, according to the Collective Bargaining Agreement. The Niners also could just waive Campbell outright, which would allow him potentially to be claimed or signed by another team. Campbell signed a $5m, one-year contract with San Francisco in March. Campbell had started 12 of the first 13 games of the season and played 90% of defensive snaps for the 49ers but was benched Thursday night after Dre Greenlaw came back for his first game since tearing his left achilles tendon in last season’s Super Bowl. When the 49ers wanted to put Campbell in the game in the third quarter because Greenlaw was sidelined with soreness in his Achilles tendon, Campbell refused, something Shanahan said has never happened to him in his time as a head coach or an assistant in the NFL . Shanahan said Friday that he has not gotten any explanation from Campbell on why he didn’t play. Campbell then walked off the field with a towel draped over his head and went into the locker room before the end of the game with the Rams that almost ended the 49ers’ playoff hopes. Shanahan said he didn’t send Campbell to the locker room and didn’t know why he left the field. “Once I found out he wasn’t playing, I moved on to people we could count on,” he said. Campbell’s decision left his teammates angered and bewildered. “He’s a professional,” cornerback Charvarius Ward said after the game. “He’s been playing for a long time. If he didn’t want to play, he shouldn’t have dressed out. He could have told them before the game. So I feel like that was selfish. It definitely hurt the team. Dre went down and we needed a linebacker. ... For him to do that, that’s sucker shit in my opinion. He’s probably going to get cut soon.” Ward is one of several 49ers who has played through injury or personal tragedy during a trying season for San Francisco. Ward’s one-year-old daughter died on 28 October but he has returned and played the last three games for San Francisco. Tight end George Kittle called Campbell’s actions “stupid” and “immature”. “It’s one person making a selfish decision,” Kittle said. “I’ve never been around anybody that’s ever done that and I hope I’m never around anybody who does that again.” The 31-year-old Campbell signed in the offseason with San Francisco after being cut by Green Bay in March. He had been an All-Pro in 2021 for the Packers but his play fell off the last two seasons in Green Bay. That led to Campbell complaining on social media that he was misused by Green Bay. He expressed excitement about being with a new team but he never got back to his All-Pro level. Campbell had a few bright moments in San Francisco this season but struggled frequently with tackling and in coverage.WARREN, N.J., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN ), a clinical-stage specialty immunotherapy biotech developing off-the-shelf, genetically unmodified T cell therapeutics to treat infectious disease and cancers, today expresses gratitude to shareholders for their unwavering support and trust in Tevogen Bio and its leadership. The commitment fuels the company’s determination to advance its mission of developing accessible, life-saving therapeutics. The company recently announced significant progress through its third quarter financial results for 2024, including, reduction of a net loss by $52.5 million, elimination of nearly all liabilities, and reiterating availability of sufficient capital to fund operations for the next 33 months. Ryan Saadi, MD, MPH, Founder and CEO, Tevogen Bio commented, "We remain steadfast in our mission to advance medical science, however as CEO of the company, preservation of shareholder value remains a priority. We urge all stakeholders to consider the profound impact short selling innovative healthcare companies has on lifesaving therapies. While stock price fluctuations are part of the public market dynamics, Tevogen Bio is acutely aware of the undue influence short sellers have.” William Keane, VP of Strategic Initiatives, and graduate of the FBI National Academy stated, “We are aware and monitoring the actions of potential short selling activity targeting our company. We will continue to bring light to this situation and will work with the appropriate authorities as needed.” The company plans to provide further updates on its progress in the coming weeks. About Tevogen Bio Tevogen is a clinical-stage specialty immunotherapy company harnessing one of nature’s most powerful immunological weapons, CD8+ cytotoxic T lymphocytes, to develop off-the-shelf, genetically unmodified precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders, aiming to address the significant unmet needs of large patient populations. Tevogen Leadership believes that sustainability and commercial success in the current era of healthcare rely on ensuring patient accessibility through advanced science and innovative business models. Tevogen has reported positive safety data from its proof-of-concept clinical trial, and its key intellectual property assets are wholly owned by the company, not subject to any third-party licensing agreements. These assets include three granted patents, nine pending US and twelve ex-US pending patents, two of which are related to artificial intelligence. Tevogen is driven by a team of highly experienced industry leaders and distinguished scientists with drug development and global product launch experience. Tevogen’s leadership believes that accessible personalized therapeutics are the next frontier of medicine, and that disruptive business models are required to sustain medical innovation. Forward-Looking Statements This press release contains certain forward-looking statements, including without limitation statements relating to: expectations regarding the healthcare and biopharmaceutical industries; Tevogen’s development of, the potential benefits of, and patient access to its product candidates for the treatment of infectious diseases, cancer and neurological disorders, including TVGN 489 for the treatment of COVID-19 and Long COVID; Tevogen’s ability to develop additional product candidates, including through use of Tevogen’s ExacTcell platform; the anticipated benefits of ExacTcell; expectations regarding Tevogen’s future clinical trials; and Tevogen’s ability to generate revenue in the future. Forward-looking statements can sometimes be identified by words such as “may,” “could,” “would,” “expect,” “anticipate,” “possible,” “potential,” “goal,” “opportunity,” “project,” “believe,” “future,” and similar words and expressions or their opposites. These statements are based on management’s expectations, assumptions, estimates, projections and beliefs as of the date of this press release and are subject to a number of factors that involve known and unknown risks, delays, uncertainties and other factors not under the company’s control that may cause actual results, performance or achievements of the company to be materially different from the results, performance or other expectations expressed or implied by these forward-looking statements. Factors that could cause actual results, performance, or achievements to differ from those expressed or implied by forward-looking statements include, but are not limited to: that Tevogen will need to raise additional capital to execute its business plan, which may not be available on acceptable terms or at all; the effect of the recent business combination with Semper Paratus Acquisition Corporation (the “Business Combination”) on Tevogen’s business relationships, operating results, and business generally; the outcome of any legal proceedings that may be instituted against Tevogen; changes in the markets in which Tevogen competes, including with respect to its competitive landscape, technology evolution, or regulatory changes; changes in domestic and global general economic conditions; the risk that Tevogen may not be able to execute its growth strategies or may experience difficulties in managing its growth and expanding operations; the risk that Tevogen may not be able to develop and maintain effective internal controls; costs related to the Business Combination and the failure to realize anticipated benefits of the Business Combination; the failure to achieve Tevogen’s commercialization and development plans and identify and realize additional opportunities, which may be affected by, among other things, competition, the ability of Tevogen to grow and manage growth economically and hire and retain key employees; the risk that Tevogen may fail to keep pace with rapid technological developments to provide new and innovative products and services or make substantial investments in unsuccessful new products and services; the ability to develop, license or acquire new therapeutics; that Tevogen will need to raise additional capital to execute its business plan, which may not be available on acceptable terms or at all; the risk of regulatory lawsuits or proceedings relating to Tevogen’s business; uncertainties inherent in the execution, cost, and completion of preclinical studies and clinical trials; risks related to regulatory review, approval and commercial development; risks associated with intellectual property protection; Tevogen’s limited operating history; and those factors discussed or incorporated by reference in Tevogen’s Annual Report on Form 10-K and subsequent filings with the SEC. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. Tevogen undertakes no obligation to update any forward-looking statements, except as required by applicable law. Contacts Tevogen Bio Communications T: 1 877 TEVOGEN, Ext 701 Communications@Tevogen.com
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Humacyte To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in Humacyte between May 10, 2024 and October 17, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310) . [You may also click here for additional information] NEW YORK, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP , a leading national securities law firm, is investigating potential claims against Humacyte, Inc. (“Humacyte” or the “Company”) (NASDAQ: HUMA) and reminds investors of the January 17, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com . As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) that the Company's Durham, North Carolina facility failed to comply with good manufacturing practices, including quality assurance and microbial testing; (2) that the FDA's review of the BLA would be delayed while Humacyte remediated these deficiencies; and (3) that, as a result, there was a substantial risk to FDA approval of ATEV for vascular trauma; and (4) that, as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis. On August 9, 2024, after the market closed, Humacyte issued a press release announcing that the Food and Drug Administration ("FDA") "will require additional time to complete its review of its Biologic License Application (BLA) for the acellular tissue engineered vessel (ATEV) in the vascular trauma indication." The press release disclosed in part, that, "[d]uring the course of the BLA review, the FDA has conducted inspections of our manufacturing facilities and clinical sites and has actively engaged with us in multiple discussions regarding our BLA filing[.]" On this news, the Company's stock price declined $1.29, or 16.4%, to close at $6.62 per share on August 12, 2024, on unusually heavy volume. On October 17, 2024, during market hours, the FDA released a Form 483 concerning Humacyte's Durham, North Carolina facility, which revealed a number of violations, including "no microbial quality assurance," "no microbial testing," and inadequate "quality oversight." On this news, the Company's stock price declined $0.95, or 16.35%, to close at $4.86 per share on October 17, 2024, on unusually heavy volume. The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not. Faruqi & Faruqi, LLP also encourages anyone with information Humacyte’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others. To learn more about the Humacyte class action, go to www.faruqilaw.com/HUMA or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310) . Follow us for updates on LinkedIn , on X , or on Facebook . Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP ( www.faruqilaw.com ). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner. A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/807ffe71-382e-48fd-91d1-846d96405715
Intuitive Surgical's EVP Robert DeSantis sells $214,655 in stock
None
Inside McDonald's plan to launch a 'McValue' deal: Here's how much you could save READ MORE: Trump Jr spills about RFK Jr and McDonald's meal in viral photo By JAMES CIRRONE FOR DAILYMAIL.COM Published: 14:22 EST, 21 November 2024 | Updated: 15:36 EST, 21 November 2024 e-mail 11 View comments McDonald's is reportedly continuing its strategy of offering cheap meal bundles into 2025. The chain's latest 'McValue' gambit builds on the $5 meal deal it introduced this summer by allowing customers to choose a $1 add-on, CNBC reported. The McDonald's $5 deal includes either a McChicken or McDouble, four-piece chicken nuggets, fries and a drink. Next year, customers who buy this meal will be able to add any of the following for just a dollar: a double cheeseburger; McChicken sandwich; six piece chicken nuggets and small fry; or breakfast options of a Sausage McMuffin, sausage biscuit or sausage burrito and a hash brown. The $5 deal has been extended through the end of 2024 by most franchisees, and if this buy one, get one for $1 tweak is approved, it will continue throughout next year. Operators are still voting on the 2025 value offerings, but this initiative is likely to pass, two people familiar told CNBC. McDonald's already has several other limited-time deals on its mobile app , including 10 piece nuggets for $1 . McDonald's told CNBC: 'We and our franchisees have heard customers loud and clear when it comes to keeping prices as affordable as possible. 'From the popular $5 Meal Deal, to numerous local and in-App offers on the food they love – we went big on value this summer and fall, bringing fans even more ways to save when they visit McDonald's. 'And as we look to 2025, we're cooking up something even bigger. We can't wait to share what's in store.' The McDonald's $5 Meal Deal consists of a McDouble or McChicken, small fries, four-piece chicken nuggets, and a small drink for $5 The company's stock bottomed out in July, coinciding with a dismal earnings result in the April through June quarter that executives blamed on low-income customers skipping trips to the golden arches due to cost. Shares rebounded throughout the latter part of the summer and into the fall, topping out at $316.56 on October 18. Investors soured on McDonald's days later when news broke on October 22 that there had been a widespread E. coli outbreak at its restaurants spanning from September 12 to October 21. The outbreak was discovered in locations across 14 states and was linked to the slivered onions on the Quarter Pounders. So far, it's left 34 people hospitalized, one man dead and 104 people sick . McDonald's plans to shell out $100 million to lure back its customers by investing in recovery efforts and supporting 'the most heavily impacted franchisees.' Shares are down more than 9 percent since the foodborne illness incident. McDonald's executives are heading into 2025 with value conscious customers on their minds. They plan to extend the $5 meal deal and allow a $1 add-on It could be three weeks before many McDonald's restaurants get back to serving espresso-based drinks while the machine manufacturer Melitta investigates the faulty part in its espresso machines Read More Dollar General announces MAJOR Thanksgiving deals ahead of holiday weekend McDonald's faced another setback this week when it came to their espresso makers . The manufacturer who makes the chain's espresso machines, Melitta, warned franchisees via letter that there was a faulty part in them, The Wall Street Journal reported. The fault could cause steam to forcefully escape from the machine and cause the part to break, according to the letter. Melitta told restaurant operators not to use the machines for three weeks while it investigates the problem and inspects the espresso makers. Lattes, mochas, macchiatos, cappuccinos and other espresso-based drinks were unavailable at some McDonald's locations in New York City and Chicago on Wednesday. McDonald's said this issue affected a limited number of drinks on the menu, with hot and ice brewed coffees still available to order. Consumer Finance Share or comment on this article: Inside McDonald's plan to launch a 'McValue' deal: Here's how much you could save e-mail Add commentNone
After his team's 102-89 home win on Wednesday night over Purdue Fort Wayne, Penn State coach Mike Rhoades challenged his team's fan base to show up and make more noise. "Sweat with us," he said at one point. At 5-0, the Nittany Lions haven't had to sweat much to get off to a fast start. They might not have to expend much perspiration to make it 6-0 on Monday when they meet Fordham in a semifinal matchup at the Sunshine Slam tournament in Daytona Beach, Fla. Penn State hasn't played a strong schedule so far, but the team has been impressive. It's averaging 98.2 points per game and 13.8 steals per game, both of which ranked second in Division I through Saturday's play. The Nittany Lions were seventh per kenpom.com in turnover rate, forcing 25.3 per 100 possessions. Point guard Ace Baldwin Jr. is leading the charge, scoring 16.4 points and dishing out 7.8 assists while chipping in 2.6 steals. Zach Hicks has nearly doubled his scoring average from 8.4 last season to 15.8 this season, while Northern Illinois transfer Yanic Konan Niederhauser has beefed up the interior, tallying 12.2 points and 7.2 rebounds. Meanwhile, Fordham (3-3) is coming off a 73-71 home loss Friday night against Drexel in New York. The Rams blew a seven-point lead early in the second half and missed a chance to force overtime when leading scorer Jackie Johnson III missed a layup as time expired. Johnson, a UNLV transfer, is averaging 19 points per game and is making nearly 48 percent of his shots as one of three Rams with double-figure scoring averages. Jahmere Tripp scores at an 11.0 clip while Japhet Medor is contributed 10.5, but Fordham is struggling to make shots, canning only 41.5 percent from the field. The Rams were picked for a 14th-place finish in the Atlantic 10 despite returning more scoring than any team in the league except for VCU. Third-year coach Keith Urgo thinks his team can defy low external expectations. "We're experienced and I think we're poised to have a tremendous year," he said. --Field Level MediaAKRON, Ohio (AP) — Nate Johnson scored 25 points to help Akron defeat Alabama State 97-78 on Sunday. Johnson added five rebounds for the Zips (4-2). Bowen Hardman scored 19 points, shooting 6 for 7 from beyond the arc. Isaiah Gray went 4 of 7 from the field to finish with 11 points. The Hornets (3-3) were led by CJ Hines with 19 points. Tyler Mack added 18 points and Antonio Madlock scored 17. Akron took the lead with 6:46 left in the first half and did not relinquish it. Johnson led their team in scoring with 13 points in the first half to help put them up 50-41 at the break. The Associated Press created this story using technology provided by Data Skrive and data from Sportradar .
What channel is Arizona vs. Duke on today? Time, TV schedule, live stream to watch college basketball game | Sporting News
None